Our focus lies in providing solutions for clinical research, including data analysis, trial optimization, clinical trials trainings and personalized drug development. We uphold the highest standards of clinical ethics, data privacy, transparency, and collaboration; ensuring every advancement is both groundbreaking and responsible.
To be the driving force behind clinical research & biomedical research excellence in Saudi Arabia, empowering professionals with cutting-edge tools and expertise to advance the innovative solutions in clinical, biomedical and healthcare research.
Advance capabilities of clinical organizations professionals with innovative AI solutions and cutting-edge capacity development, expert biostatistical & clinical research Services; enabling efficient, ethical, and data-driven clinical management & biomedical research.
We uphold the highest standards of clinical ethics, data privacy, transparency, and collaboration; ensuring every advancement is both groundbreaking and responsible.
Our efforts are aligned with Saudi Arabia's National Biotechnology Strategy, which aspires to position the nation as a global leader in biotechnology by 2040. By leveraging AI, we aim to enhance clinical research efficiency, accelerate medical breakthroughs, and improve patient outcomes, all while contributing to the country's Vision 2030.
We are dedicated to fostering a sustainable talent ecosystem by delivering tailored training programs designed to meet the evolving needs of the clinical research and biotech sectors. Our focus is on cultivating a skilled workforce capable of leading future innovations.
Through AI optimization, we aim to unlock the full potential of Saudi Arabia's existing infrastructure in research and development. Our solutions target key areas such as vaccine development, biomanufacturing, and genomics, driving economic growth, creating high-quality jobs, and improving the well-being of citizens.
Harness the power of AI to streamline clinical trial management, enhance data analytics, and optimize patient recruitment processes. By integrating AI technology with human expertise, we significantly reduce research timelines while improving clinical outcomes.
We empower healthcare professionals with advanced AI skills and knowledge, enabling them to effectively design, conduct, and analyze clinical trials. Our tailored training programs equip them to lead innovation in AI-powered clinical research.
We provide expert consultancy services to ensure that clinical research projects are conducted in line with global best practices and comply with international regulatory standards, ensuring both ethical and efficient project execution.
Leverage AI to streamline clinical trials, enhance data analysis, and provide customized AI solutions to improve patient outcomes, such as predictive analytics for disease risk assessment, personalized medicine recommendations, and drug discovery acceleration.
Empower healthcare professionals and create a sustainable pool of skilled professionals through implementing tailored clinical research talent development programs for specific requirements of the Clinical Research & biotech industry.
Consultancy services include CRO/SMO that leverages AI to streamline various aspects of clinical trials, including patient recruitment, data management, and analysis, ensuring faster and more accurate results.
ISD’s soft-landing services are designed to help healthcare, biotech and pharmaceutical companies establish a strong presence in Saudi Arabia with ease and confidence.
ISD provides tailored support to navigate the complexities of entering the Saudi market, including:Feasibility services for biotech & healthcare, regulatory packages to land in KSA and Governance & Business Development
January 27th & 28th
Febuary 4th & 5th
TBD
Intelligent Solutions Discovery (ISD) attended the inaugural CPHI Middle East event Dec 10-12, Riyadh.
CPHI Middle East brought together key players from the region and beyond, fostering dynamic exchanges on emerging trends, regulatory developments, and growth opportunities within the Middle East's rapidly evolving healthcare landscape.
Eng. Hani Ashqar, CEO of Intelligent Solutions Discovery, emphasized that "we were thrilled to be a part of the first-ever CPHI Middle East. The event provided invaluable insights into the unique challenges and opportunities within the regional pharmaceutical market".
The event proved to be a resounding success, offering a vibrant platform for stakeholders across the pharmaceutical industry to connect and explore the latest advancements in the field.
Intelligent Solutions Discovery attended the "Riyadh Global Medical Biotechnology Summit" and had very impactful conversations and meetings. The event marked an important milestone in the region's burgeoning healthcare sector and underscored Saudi Arabia's commitment to prioritizing advancements in biomedical research, particularly in clinical research and drug development. Eng. Hani Ashqar, CEO of Intelligent Solutions Discovery, remarked, "This event has successfully brought together a significant number of major global stakeholders, fostering a collaborative environment to drive ecosystem development and business growth within the Saudi pharmaceutical sector. The opportunities presented here are immense, and we at Intelligent Solutions Discovery are excited to be part of this transformative journey." From Saudi to the world, there is a promising biotech future for humanity!
Eng. Hani Ashqar, CEO of ISD, announced the launch and highlighted the company's dedication to advancing healthcare in Saudi Arabia. Intelligent Solutions Discovery (ISD), a new company leveraging Al to revolutionize drug discovery and development, officially launched at the Global Health Exhibition Riyadh Oct 20-23, 2024.
The Global Health Exhibition demonstrated Saudi Arabia's commitment to becoming a global leader in healthcare innovation. "ISD is proud to launch here and contribute to the Kingdom's Vision 2030 by accelerating the development of life-saving treatments through Al-powered solutions."
ISD aims to streamline and optimize drug development by utilizing cutting-edge artificial intelligence. The company's presence at this premier global health event underscores its dedication to international collaboration and contributing to the growing biomedical research ecosystem in Saudi Arabia.
"This event served as a key platform for knowledge sharing and collaboration in the healthcare sector, focusing on innovation and technological advancements. ISD's launch here positions the company as a key player in the global health arena in KSA. The event brought together many companies and healthcare organizations to form collaborations," said Eng. Hani Ashqar, CEO, Intelligent Solutions Discovery.
A dynamic leader with 20+ years of executive experience in operations, business development, and finance across industry, academia, NGO, and government sectors.
Over two decades of pharmaceutical R&D, Clinical Research, and Drug Development through clinical trials globally across pharma and academia.
Senior KAUST Faculty and brings the great strength in bioinformatics & AI in healthcare.